Fonte: Atherosclerosis. Nome do evento: Congress of the European Atherosclerosis Society/EAS. Unidades: FM, FCF
Assuntos: APNEIA DO SONO, DOENÇAS CARDIOVASCULARES
ABNT
DRAGER, Luciano Ferreira et al. Chylomicron metabolism is impaired in patients with obstructive sleep apnea: effects of treatment with continuous positive airway pressure. Atherosclerosis. Clare: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://eas2018.com/wp-content/uploads/2018/05/EAS2018-programme.pdf. Acesso em: 05 set. 2024. , 2018APA
Drager, L. F., Tavoni, T. M., Silva, V. M. da, Santos, R. D. dos, Pedrosa, R. P., Bortolotto, L. A., et al. (2018). Chylomicron metabolism is impaired in patients with obstructive sleep apnea: effects of treatment with continuous positive airway pressure. Atherosclerosis. Clare: Faculdade de Medicina, Universidade de São Paulo. Recuperado de https://eas2018.com/wp-content/uploads/2018/05/EAS2018-programme.pdfNLM
Drager LF, Tavoni TM, Silva VM da, Santos RD dos, Pedrosa RP, Bortolotto LA, Vinagre CGC de M, Polotsky VY, Lorenzi Filho G, Maranhão RC. Chylomicron metabolism is impaired in patients with obstructive sleep apnea: effects of treatment with continuous positive airway pressure [Internet]. Atherosclerosis. 2018 ; 275 e157 res. P2.2.182.[citado 2024 set. 05 ] Available from: https://eas2018.com/wp-content/uploads/2018/05/EAS2018-programme.pdfVancouver
Drager LF, Tavoni TM, Silva VM da, Santos RD dos, Pedrosa RP, Bortolotto LA, Vinagre CGC de M, Polotsky VY, Lorenzi Filho G, Maranhão RC. Chylomicron metabolism is impaired in patients with obstructive sleep apnea: effects of treatment with continuous positive airway pressure [Internet]. Atherosclerosis. 2018 ; 275 e157 res. P2.2.182.[citado 2024 set. 05 ] Available from: https://eas2018.com/wp-content/uploads/2018/05/EAS2018-programme.pdf